Cited by 98Hematopoietic Stem Cell TransplantationMesenchymal stem cell researchBlood disorders and treatments

Self-Renewal of Multipotent Long-Term Repopulating Hematopoietic Stem Cells Is Negatively Regulated by FAS and Tumor Necrosis Factor Receptor Activation

Open access
Bryder, David, Ramsfjell, Veslemøy, Dybedal, Ingunn, Theilgaard-Mönch, Kim, Högerkorp, Carl-Magnus, Adolfsson, Jörgen, Borge, Ole Johan, Jacobsen, Sten Eirik W.·2001·The Journal of Experimental Medicine

Abstract

Multipotent self-renewing hematopoietic stem cells (HSCs) are responsible for reconstitution of all blood cell lineages. Whereas growth stimulatory cytokines have been demonstrated to promote HSC self-renewal, the potential role of negative regulators remains elusive. Receptors for tumor necrosis factor (TNF) and Fas ligand have been implicated as regulators of steady-state hematopoiesis, and if overexpressed mediate bone marrow failure. However, it has been proposed that hematopoietic progenitors rather than stem cells might be targeted by Fas activation. Here, murine Lin−Sca1+c-kit+ stem cells revealed little or no constitutive expression of Fas and failed to respond to an agonistic anti-Fas antibody. However, if induced to undergo self-renewal in the presence of TNF-α, the entire short and long-term repopulating HSC pool acquired Fas expression at high levels and concomitant activation of Fas suppressed in vitro growth of Lin−Sca1+c-kit+ cells cultured at the single cell level. Moreover, Lin−Sca1+c-kit+ stem cells undergoing self-renewal divisions in vitro were severely and irreversibly compromised in their short- and long-term multilineage reconstituting ability if activated by TNF-α or through Fas, providing the first evidence for negative regulators of HSC self-renewal.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.194.7.941

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TP53-heterozygous HSPC from pre-TP53-sAML patients showed downregulation of TNFα- and TGFβ-associated gene signatures, with upregulated expression of oxidative phosphorylation, DNA repair and interferon (IFN) response genes, without changes in IFN receptor expression levels or concurrent IFN treatment.

    “TP53-heterozygous HSPC from pre-TP53-sAML patients showed downregulation of TNFα- and TGFβ-associated gene signatures, both of which are known to be associated with HSC attrition32,33, with upregulated expression of oxidative phosphorylation, DNA repair and interferon (IFN) response genes (Supplementary Table 5 and Fig. 4c–e), without changes in IFN receptor expression levels or concurrent IFN”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 65

  1. Domen J. Weissman I.L. Self-renewal, differentiation or deathregulation and manipulation of hematopoietic stem cell fate Mol. Med. Today. 5 1999 201 208 10322312
  2. Metcalf D. Hematopoietic regulatorsredundancy or subtlety? Blood. 82 1993 3515 3523 8260692
  3. Ogawa M. Differentiation and proliferation of hematopoietic stem cells Blood. 81 1993 2844 2853 8499622
  4. Akashi K. Kondo M. von Freeden-Jeffry U. Murray R. Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice Cell. 89 1997 1033 1041 9215626
  5. Fairbairn L.J. Cowling G.J. Reipert B.M. Dexter T.M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors Cell. 74 1993 823 832 7690686
  6. Lagasse E. Weissman I.L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice Cell. 89 1997 1021 1031 9215625
  7. Maraskovsky E. O'Reilly L.A. Teepe M. Corcoran L.M. Peschon J.J. Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice Cell. 89 1997 1011 1019 9215624
  8. Jacobsen S.E. Jacobsen F.W. Fahlman C. Rusten L.S. TNF-alpha, the great imitatorrole of p55 and p75 TNF receptors in hematopoiesis Stem Cells. 12 1994 111 126 7535144
  9. Mori T. Nishimura T. Ikeda Y. Hotta T. Yagita H. Ando K. Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression Blood. 92 1998 101 107 9639505
  10. Traver D. Akashi K. Weissman I.L. Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia Immunity. 9 1998 47 57 9697835
  11. Zhang Y. Harada A. Bluethmann H. Wang J.B. Nakao S. Mukaida N. Matsushima K. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cellsincrease of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro Blood. 86 1995 2930 2937 7579385
  12. Jacobsen F.W. Rothe M. Rusten L. Goeddel D.V. Smeland E.B. Veiby O.P. Slordal L. Jacobsen S.E. Role of the 75-kDa tumor necrosis factor receptorinhibition of early hematopoiesis Proc. Natl. Acad. Sci. USA. 91 1994 10695 10699 7524102 PMC45088
  13. Rebel V.I. Hartnett S. Hill G.R. Lazo-Kallanian S.B. Ferrara J.L. Sieff C.A. Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level J. Exp. Med. 190 1999 1493 1504 10562323 PMC2195701
  14. Spangrude G.J. Brooks D.M. Tumas D.B. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cellsin vivo expansion of stem cell phenotype but not function Blood. 85 1995 1006 1016 7849289
  15. Gersuk G.M. Beckham C. Loken M.R. Kiener P. Anderson J.E. Farrand A. Troutt A.B. Ledbetter J.A. Deeg H.J. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome Br. J. Haematol. 103 1998 176 188 9792306
  16. Hinterberger W. Adolf G. Bettelheim P. Geissler K. Huber C. Irschick E. Kalhs P. Koller U. Lechner K. Meister B. Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions Blood. 74 1989 2713 2717 2479429
  17. Young N.S. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia Semin. Hematol. 37 2000 3 14 10676907
  18. Maciejewski J. Selleri C. Anderson S. Young N.S. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro Blood. 85 1995 3183 3190 7538820
  19. Rosselli F. Sanceau J. Gluckman E. Wietzerbin J. Moustacchi E. Abnormal lymphokine productiona novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha Blood. 83 1994 1216 1225 8118026
  20. Schneider E. Moreau G. Arnould A. Vasseur F. Khodabaccus N. Dy M. Ezine S. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice Blood. 94 1999 2613 2621 10515865
  21. Seipelt G. Ganser A. Duranceyk H. Maurer A. Ottmann O.G. Hoelzer D. Induction of TNF-alpha in patients with myelodysplastic syndromes undergoing treatment with interleukin-3 Br. J. Haematol. 84 1993 749 751 8217838
  22. Verhoef G.E. De Schouwer P. Ceuppens J.L. Van Damme J. Goossens W. Boogaerts M.A. Measurement of serum cytokine levels in patients with myelodysplastic syndromes Leukemia. 6 1992 1268 1272 1280751
  23. Aguila H.L. Weissman I.L. Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells Blood. 87 1996 1225 1231 8608208
  24. Bryder D. Jacobsen S.E. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro Blood. 96 2000 1748 1755 10961873
  25. Ramsfjell V. Bryder D. Bjorgvinsdottir H. Kornfalt S. Nilsson L. Borge O.J. Jacobsen S.E. Distinct requirements for optimal growth and In vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells Blood. 94 1999 4093 4102 10590054
  26. Miller C.L. Eaves C.J. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability Proc. Natl. Acad. Sci. USA. 94 1997 13648 13653 9391080 PMC28360
  27. Ema H. Takano H. Sudo K. Nakauchi H. In vitro self-renewal division of hematopoietic stem cells J. Exp. Med. 192 2000 1281 1288 11067877 PMC2193353
  28. Ikuta K. Weissman I.L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation Proc. Natl. Acad. Sci. USA. 89 1992 1502 1506 1371359 PMC48479
  29. Okada S. Nakauchi H. Nagayoshi K. Nishikawa S. Miura Y. Suda T. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells Blood. 80 1992 3044 3050 1281687
  30. Spangrude G.J. Heimfeld S. Weissman I.L. Purification and characterization of mouse hematopoietic stem cells Science. 241 1988 58 62 2898810
  31. Spangrude G.J. Scollay R. A simplified method for enrichment of mouse hematopoietic stem cells Exp. Hematol. 18 1990 920 926 1974864
  32. Matsuoka S. Ebihara Y. Xu M. Ishii T. Sugiyama D. Yoshino H. Ueda T. Manabe A. Tanaka R. Ikeda Y. CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages Blood. 97 2001 419 425 11154218
  33. Ito T. Tajima F. Ogawa M. Developmental changes of CD34 expression by murine hematopoietic stem cells Exp. Hematol. 28 2000 1269 1273 11063875
  34. Theilgaard-Monch K. Cowland J. Borregaard N. Profiling of gene expression in individual hematopoietic cells by global mRNA amplification and slot blot analysis J. Immunol. Methods. 252 2001 175 189 11334978
  35. Harrison D.E. Competitive repopulationa new assay for long-term stem cell functional capacity Blood. 55 1980 77 81 6985804
  36. Dybedal I. Guan F. Borge O.J. Veiby O.P. Ramsfjell V. Nagata S. Jacobsen S.E. Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells Blood. 90 1997 3395 3403 9345022
  37. Li C.L. Johnson G.R. Murine hematopoietic stem and progenitor cellsI. Enrichment and biologic characterization Blood. 85 1995 1472 1479 7534130
  38. Osawa M. Nakamura K. Nishi N. Takahasi N. Tokuomoto Y. Inoue H. Nakauchi H. In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/−) hemopoietic stem cells J. Immunol. 156 1996 3207 3214 8617942
  39. Nagafuji K. Shibuya T. Harada M. Mizuno S. Takenaka K. Miyamoto T. Okamura T. Gondo H. Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells Blood. 86 1995 883 889 7542501
  40. Osawa M. Hanada K. Hamada H. Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34- low/negative hematopoietic stem cell Science. 273 1996 242 245 8662508
  41. Sato T. Laver J.H. Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells Blood 94 1999 2548 2554 10515856
  42. Morrison S.J. Weissman I.L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype Immunity. 1 1994 661 673 7541305
  43. Harrison D.E. Stone M. Astle C.M. Effects of transplantation on the primitive immunohematopoietic stem cell J. Exp. Med. 172 1990 431 437 1973702 PMC2188322
  44. Jones R.J. Celano P. Sharkis S.J. Sensenbrenner L.L. Two phases of engraftment established by serial bone marrow transplantation in mice Blood. 73 1989 397 401 2563661
  45. Fortunel N.O. Hatzfeld A. Hatzfeld J.A. Transforming growth factor-betapleiotropic role in the regulation of hematopoiesis Blood. 96 2000 2022 2036 10979943
  46. Graham G.J. Wright E.G. Hewick R. Wolpe S.D. Wilkie N.M. Donaldson D. Lorimore S. Pragnell I.B. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation Nature. 344 1990 442 444 2320111
  47. Miller J.S. McCullar V. Verfaillie C.M. Ex vivo culture of CD34+/Lin−/DR− cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay Blood. 91 1998 4516 4522 9616147
  48. Capmany G. Querol S. Cancelas J.A. Garcia J. Short-term, serum-free, static culture of cord blood-derived CD34+ cellseffects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells Haematologica. 84 1999 675 682 10457401
  49. Wiesmann A. Kim M. Georgelas A. Searles A.E. Cooper D.D. Green W.F. Spangrude G.J. Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor beta Exp. Hematol. 28 2000 128 139 10706068
  50. Soma T. Yu J.M. Dunbar C.E. Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-beta but not macrophage inflammatory protein-1 alpha activities Blood. 87 1996 4561 4567 8639824
  51. Nagata S. Suda T. Fas and Fas ligandlpr and gld mutations Immunol. Today. 16 1995 39 43 7533498
  52. Smith C.A. Farrah T. Goodwin R.G. The TNF receptor superfamily of cellular and viral proteinsactivation, costimulation, and death Cell. 76 1994 959 962 8137429
  53. Maciejewski J.P. Selleri C. Sato T. Anderson S. Young N.S. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia Br. J. Haematol. 91 1995 245 252 7577642
  54. Vinci G. Chouaib S. Autran B. Vernant J.P. Evidence that residual host cells surviving the conditioning regimen to allogeneic bone marrow transplantation inhibit donor hematopoiesis in vitro—the role of TNF-alpha Transplantation. 52 1991 406 411 1897009
  55. Wiesmann A. Phillips R.L. Mojica M. Pierce L.J. Searles A.E. Spangrude G.J. Lemischka I. Expression of CD27 on murine hematopoietic stem and progenitor cells Immunity. 12 2000 193 199 10714685
  56. Baxter G.T. Kuo R.C. Jupp O.J. Vandenabeele P. MacEwan D.J. Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression J. Biol. Chem. 274 1999 9539 9547 10092639
  57. Barcena A. Park S.W. Banapour B. Muench M.O. Mechetner E. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver Blood. 88 1996 2013 2025 8822920
  58. Lee S.J. Zhou T. Choi C. Wang Z. Benveniste E.N. Differential regulation and function of Fas expression on glial cells J. Immunol. 164 2000 1277 1285 10640741
  59. Ouaaz F. Li M. Beg A.A. A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death J. Exp. Med. 189 1999 999 1004 10075983 PMC2193051
  60. Zheng Y. Ouaaz F. Bruzzo P. Singh V. Gerondakis S. Beg A.A. Nf-kappab rela (p65) is essential for tnf-alpha-induced fas expression but dispensable for both tcr-induced expression and activation-induced cell death J. Immunol. 166 2001 4949 4957 11290773
  61. Grell M. Krammer P.H. Scheurich P. Segregation of APO-1/Fas antigen- and tumor necrosis factor receptor-mediated apoptosis Eur. J. Immunol. 24 1994 2563 2566 7523147
  62. Schulze-Osthoff K. Krammer P.H. Droge W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death EMBO J. 13 1994 4587 4596 7523113 PMC395391
  63. Wong G.H. Goeddel D.V. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways J. Immunol. 152 1994 1751 1755 7509828
  64. Williams D.A. Ex vivo expansion of hematopoietic stem and progenitor cells—robbing Peter to pay Paul? Blood. 81 1993 3169 3172 8507858
  65. Peters S.O. Kittler E.L. Ramshaw H.S. Quesenberry P.J. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL- 6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts Blood. 87 1996 30 37 8547656

Cited by

Sorted by citations

Authors
Bryder, D., Ramsfjell, V., Dybedal, I., Theilgaard-Mönch, K., Högerkorp, C.-M., Adolfsson, J., Borge, O. J., & Jacobsen, S. E. W.
Affiliations
  • Skåne University Hospital (SE)
  • bThe Granulocyte Research Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark
Venue
The Journal of Experimental Medicine
Published
2001-10-01
Volume
194
Issue
7
Pages
941-952
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2137350608
Cited by
98
References
1
Citations by year
2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 7 · 2013: 2 · 2012: 5
FWCI
3.08
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Blood disorders and treatments
Keywords
hematopoietic stem cells, self-renewal, Fas, TNF receptor, TNF-α, negative regulation, multilineage reconstitution, bone marrow failure, Fas ligand
MeSH terms
Animals, Antigens, Ly, Cell Division, Cell Separation, Cells, Cultured, Hematopoiesis, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Tumor Necrosis Factor-alpha, Bone Marrow Transplantation, Receptors, Tumor Necrosis Factor, Antigens, CD34, Proto-Oncogene Proteins c-kit, fas Receptor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review